<DOC>
	<DOC>NCT02424383</DOC>
	<brief_summary>The objective of this patient registry is to assess the clinical use of the Lutonix 035 DCB PTA Catheter in a heterogeneous patient population in a real world and on-label clinical application.</brief_summary>
	<brief_title>Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter</brief_title>
	<detailed_description>The registry is a prospective, multicenter, single arm post-market real-world registry in the U.S. assessing the clinical use, safety and outcomes of the Lutonix 035 DCB Catheter in the Superficial Femoral Artery (SFA) and Popliteal Arteries (PA). Registry subjects will be followed for up to three year's post-index procedure.</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>1. The subject provides written informed consent using an Informed Consent Form (ICF) that is reviewed and approved by the Institutional Review Board (IRB) for the site. 2. The subject agrees to comply with the protocolmandated followup procedures and visits. 3. The subject is â‰¥ 21 years old. 4. The subject must have a lesion(s) that can be treated with available Lutonix 035 DCB Catheter according to IFU. 1. The subject is unable or unwilling to provide informed consent. 2. The subject is unable or unwilling to comply with the patient registry protocol followup procedures and visits. 3. The subject has another medical condition or is currently participating in an investigational drug or an investigational device study that, which, in the opinion of the Investigator, may cause him/her to be noncompliant with the protocol, confounds the data interpretation, or is associated with a life expectancy insufficient to allow for the completion of patient registry procedures and followup.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>